These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Identification of two-dimensionally separated human cerebrospinal fluid proteins by N-terminal sequencing, matrix-assisted laser desorption/ionization--mass spectrometry, nanoliquid chromatography-electrospray ionization-time of flight-mass spectrometry, and tandem mass spectrometry. Raymackers J; Daniels A; De Brabandere V; Missiaen C; Dauwe M; Verhaert P; Vanmechelen E; Meheus L Electrophoresis; 2000 Jun; 21(11):2266-83. PubMed ID: 10892737 [TBL] [Abstract][Full Text] [Related]
3. Proteomic profile of cerebrospinal fluid in patients with multiple sclerosis using two dimensional gel electrophoresis. Hassan D; Provansal M; Lehmann S; Rizk M; Moez P; Vialaret J; Hirtz C; Essa A; Agamia H Br J Biomed Sci; 2016 Jul; 73(3):143-146. PubMed ID: 27254308 [No Abstract] [Full Text] [Related]
4. Cerebrospinal fluid proteome profile in multiple sclerosis. Lehmensiek V; Süssmuth SD; Tauscher G; Brettschneider J; Felk S; Gillardon F; Tumani H Mult Scler; 2007 Aug; 13(7):840-9. PubMed ID: 17881397 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the human lumbar cerebrospinal fluid proteome. Yuan X; Russell T; Wood G; Desiderio DM Electrophoresis; 2002 Apr; 23(7-8):1185-96. PubMed ID: 11981868 [TBL] [Abstract][Full Text] [Related]
7. Proteomic pattern analysis discriminates among multiple sclerosis-related disorders. Komori M; Matsuyama Y; Nirasawa T; Thiele H; Becker M; Alexandrov T; Saida T; Tanaka M; Matsuo H; Tomimoto H; Takahashi R; Tashiro K; Ikegawa M; Kondo T Ann Neurol; 2012 May; 71(5):614-23. PubMed ID: 22522477 [TBL] [Abstract][Full Text] [Related]
8. Between-gel reproducibility of the human cerebrospinal fluid proteome. Terry DE; Desiderio DM Proteomics; 2003 Oct; 3(10):1962-79. PubMed ID: 14625859 [TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia. Jiang L; Lindpaintner K; Li HF; Gu NF; Langen H; He L; Fountoulakis M Amino Acids; 2003 Jul; 25(1):49-57. PubMed ID: 12836058 [TBL] [Abstract][Full Text] [Related]
10. A gel-based proteomic comparison of human cerebrospinal fluid between inflicted and non-inflicted pediatric traumatic brain injury. Gao WM; Chadha MS; Berger RP; Omenn GS; Allen DL; Pisano M; Adelson PD; Clark RS; Jenkins LW; Kochanek PM J Neurotrauma; 2007 Jan; 24(1):43-53. PubMed ID: 17263669 [TBL] [Abstract][Full Text] [Related]
11. Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis. Liu S; Bai S; Qin Z; Yang Y; Cui Y; Qin Y J Cell Mol Med; 2009 Aug; 13(8A):1586-603. PubMed ID: 19602050 [TBL] [Abstract][Full Text] [Related]
12. CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis. Chiasserini D; Di Filippo M; Candeliere A; Susta F; Orvietani PL; Calabresi P; Binaglia L; Sarchielli P Eur J Neurol; 2008 Sep; 15(9):998-1001. PubMed ID: 18637954 [TBL] [Abstract][Full Text] [Related]
13. Proteomic identification of potential protein markers in cerebrospinal fluid of GBS patients. Jin T; Hu LS; Chang M; Wu J; Winblad B; Zhu J Eur J Neurol; 2007 May; 14(5):563-8. PubMed ID: 17437617 [TBL] [Abstract][Full Text] [Related]
14. Proteomics of cerebrospinal fluid: methods for sample processing. Hale JE; Gelfanova V; You JS; Knierman MD; Dean RA Methods Mol Biol; 2008; 425():53-66. PubMed ID: 18369886 [TBL] [Abstract][Full Text] [Related]
15. Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation mass spectrometry. Davidsson P; Folkesson S; Christiansson M; Lindbjer M; Dellheden B; Blennow K; Westman-Brinkmalm A Rapid Commun Mass Spectrom; 2002; 16(22):2083-8. PubMed ID: 12415540 [TBL] [Abstract][Full Text] [Related]
16. Quantitative proteomic analysis of cerebrospinal fluid of women newly diagnosed with multiple sclerosis. Jankovska E; Lipcseyova D; Svrdlikova M; Pavelcova M; Kubala Havrdova E; Holada K; Petrak J Int J Neurosci; 2022 Jul; 132(7):724-734. PubMed ID: 33059501 [TBL] [Abstract][Full Text] [Related]
17. A comprehensive proteome map of bovine cerebrospinal fluid. Brenn A; Karger A; Skiba M; Ziegler U; Groschup MH Proteomics; 2009 Nov; 9(22):5199-205. PubMed ID: 19921684 [TBL] [Abstract][Full Text] [Related]
18. Sulfatide isoform pattern in cerebrospinal fluid discriminates progressive MS from relapsing-remitting MS. Novakova L; Singh AK; Axelsson M; Ståhlman M; Adiels M; Malmeström C; Zetterberg H; Borén J; Lycke J; Cardell SL; Blomqvist M J Neurochem; 2018 Aug; 146(3):322-332. PubMed ID: 29676479 [TBL] [Abstract][Full Text] [Related]
19. Posttranslational modifications of proteins are key features in the identification of CSF biomarkers of multiple sclerosis. Salazar IL; Lourenço AST; Manadas B; Baldeiras I; Ferreira C; Teixeira AC; Mendes VM; Novo AM; Machado R; Batista S; Macário MDC; Grãos M; Sousa L; Saraiva MJ; Pais AACC; Duarte CB J Neuroinflammation; 2022 Feb; 19(1):44. PubMed ID: 35135578 [TBL] [Abstract][Full Text] [Related]
20. Proteomics analysis of human cerebrospinal fluid. Yuan X; Desiderio DM J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):179-89. PubMed ID: 15652808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]